Montag & Caldwell’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $58.5K | Sell |
99
-10,651
| -99% | -$4.45M | 0.01% | 101 |
|
|
2025
Q1 | $5.36M | Sell |
10,750
-4,037
| -27% | -$2.19M | 1.24% | 31 |
|
|
2024
Q4 | $7.69M | Sell |
14,787
-1,285
| -8% | -$706K | 1.64% | 24 |
|
|
2024
Q3 | $9.94M | Sell |
16,072
-684
| -4% | -$405K | 2.02% | 23 |
|
|
2024
Q2 | $9.27M | Sell |
16,756
-4,737
| -22% | -$2.71M | 1.87% | 23 |
|
|
2024
Q1 | $12.5M | Sell |
21,493
-951
| -4% | -$534K | 2.15% | 21 |
|
|
2023
Q4 | $11.9M | Sell |
22,444
-31,047
| -58% | -$15M | 2.08% | 26 |
|
|
2023
Q3 | $27.1M | Sell |
53,491
-530
| -1% | -$282K | 3.48% | 9 |
|
|
2023
Q2 | $28.2M | Sell |
54,021
-336
| -0.6% | -$181K | 3.44% | 9 |
|
|
2023
Q1 | $31.3M | Sell |
54,357
-798
| -1% | -$450K | 4.21% | 4 |
|
|
2022
Q4 | $30.4M | Sell |
55,155
-1,613
| -3% | -$855K | 4.41% | 6 |
|
|
2022
Q3 | $28.8M | Sell |
56,768
-762
| -1% | -$426K | 4.28% | 6 |
|
|
2022
Q2 | $31.3M | Buy |
57,530
+8,702
| +18% | +$4.79M | 4.54% | 5 |
|
|
2022
Q1 | $28.8M | Sell |
48,828
-584
| -1% | -$335K | 3.21% | 12 |
|
|
2021
Q4 | $33M | Sell |
49,412
-6,265
| -11% | -$3.91M | 3.18% | 11 |
|
|
2021
Q3 | $31.8M | Buy |
55,677
+26
| +0% | +$14.3K | 2.93% | 16 |
|
|
2021
Q2 | $28.1M | Sell |
55,651
-22,172
| -28% | -$10.5M | 2.53% | 19 |
|
|
2021
Q1 | $35.5M | Sell |
77,823
-57,149
| -42% | -$27.3M | 3.25% | 13 |
|
|
2020
Q4 | $62.7M | Sell |
134,972
-25,710
| -16% | -$12.1M | 3.46% | 10 |
|
|
2020
Q3 | $70.9M | Sell |
160,682
-7,316
| -4% | -$3.02M | 4.31% | 4 |
|
|
2020
Q2 | $60.9M | Sell |
167,998
-42,725
| -20% | -$14.3M | 4.03% | 7 |
|
|
2020
Q1 | $59.8M | Sell |
210,723
-63,866
| -23% | -$20.1M | 3.97% | 9 |
|
|
2019
Q4 | $89.2M | Sell |
274,589
-8,235
| -3% | -$2.5M | 4.26% | 7 |
|
|
2019
Q3 | $82.4M | Sell |
282,824
-40,068
| -12% | -$11.5M | 4.24% | 5 |
|
|
2019
Q2 | $94.8M | Sell |
322,892
-11,057
| -3% | -$3.05M | 4.88% | 3 |
|
|
2019
Q1 | $91.4M | Sell |
333,949
-30,450
| -8% | -$7.58M | 4.77% | 3 |
|
|
2018
Q4 | $81.5M | Sell |
364,399
-94,230
| -21% | -$22.1M | 4.45% | 6 |
|
|
2018
Q3 | $112M | Sell |
458,629
-22,276
| -5% | -$5.12M | 4.37% | 6 |
|
|
2018
Q2 | $99.6M | Buy |
480,905
+13,953
| +3% | +$2.96M | 3.97% | 8 |
|
|
2018
Q1 | $96.4M | Sell |
466,952
-55,800
| -11% | -$11.7M | 3.51% | 10 |
|
|
2017
Q4 | $99.3M | Sell |
522,752
-61,088
| -10% | -$11.7M | 3.12% | 14 |
|
|
2017
Q3 | $110M | Sell |
583,840
-160,266
| -22% | -$29M | 3.4% | 11 |
|
|
2017
Q2 | $130M | Sell |
744,106
-66,745
| -8% | -$11.2M | 3.83% | 8 |
|
|
2017
Q1 | $125M | Sell |
810,851
-219,132
| -21% | -$33.5M | 3.57% | 11 |
|
|
2016
Q4 | $145M | Sell |
1,029,983
-25,003
| -2% | -$3.69M | 3.51% | 15 |
|
|
2016
Q3 | $168M | Sell |
1,054,986
-43,641
| -4% | -$6.72M | 3.53% | 13 |
|
|
2016
Q2 | $162M | Sell |
1,098,627
-49,380
| -4% | -$7.29M | 3.31% | 11 |
|
|
2016
Q1 | $163M | Sell |
1,148,007
-277,480
| -19% | -$37.2M | 2.98% | 12 |
|
|
2015
Q4 | $202M | Sell |
1,425,487
-254,119
| -15% | -$33.9M | 3.73% | 8 |
|
|
2015
Q3 | $205M | Sell |
1,679,606
-171,454
| -9% | -$22.3M | 3.42% | 10 |
|
|
2015
Q2 | $240M | Sell |
1,851,060
-377,707
| -17% | -$49.2M | 3.41% | 9 |
|
|
2015
Q1 | $299M | Sell |
2,228,767
-216,151
| -9% | -$27.9M | 3.63% | 9 |
|
|
2014
Q4 | $306M | Sell |
2,444,918
-380,201
| -13% | -$46.2M | 3.36% | 8 |
|
|
2014
Q3 | $344M | Buy |
2,825,119
+489,865
| +21% | +$59.6M | 3.57% | 8 |
|
|
2014
Q2 | $276M | Buy |
+2,335,254
| New | +$275M | 2.47% | 22 |
|
Other funds holding TMO
Montag & Caldwell's TMO Position: Q2 2025 in Review
Montag & Caldwell reduced its Thermo Fisher Scientific (TMO) stake by 99% in Q2 2025, selling an estimated $4.45M and leaving 99 shares worth $58.5K. The position accounts for 0.01% of the portfolio, ranked #101.
Montag & Caldwell first reported a position in TMO in Q2 2014 and has held it in 45 quarters since. The position peaked at $344M in Q3 2014. 2,453 funds tracked by Wall St. Rank hold TMO as of Q2 2025.
- Montag & Caldwell held 99 shares of Thermo Fisher Scientific worth $58.5K as of Q2 2025.
- Montag & Caldwell sold 10,651 Thermo Fisher Scientific shares in Q2 2025, an estimated $4.45M.
- Thermo Fisher Scientific made up 0.01% of Montag & Caldwell's portfolio in Q2 2025, its #101 holding.
- Montag & Caldwell first reported a position in Thermo Fisher Scientific in Q2 2014 and has held it in 45 quarters since.
- Montag & Caldwell's Thermo Fisher Scientific position peaked at $344M in Q3 2014.
- 2,453 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.
Based on Montag & Caldwell's 13F filing for Q2 2025, filed 15 Aug 2025.